JPRN-UMIN000003971已完成2 期
Prospective analysis of efficacy and safety of individualized administration of midazolam for sedation during bronchoscopy - Prospective analysis of midazolam administration for sedation during bronchoscopy
agoya University Graduate School of Medicine0 个研究点目标入组 200 人开始时间: 2010年7月31日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with at least one of the following conditions are ineligible. 1) Patients with type II respiratory failure who take or need home oxygen therapy 2) Patients with obstructive sleep apnea syndrome who need positive airway pressure ventilation 3) History of myocardial infarction within 6 weeks 4) Having mental disorders unable to mutual understanding 5) History of grave drug allergic reaction or allergic reaction to midazolam 6) Acute angle-closure glaucoma 7) Neuromuscular disease (such as myasthenia gravis) 8) Patients who are taking 9) Pregnancy, breast feeding and suspected pregnancy 10) Inadequate for bronchoscopy 11) Patients whose participation in the trial is judged to be inappropriate by the attendeing doctor
研究者
相似试验
进行中（未招募）
不适用
A study on efficacy and safety of insulin degludec/insulin aspart in patients with type 2 diabetesKCT0004597Seoul National University Hospital55
招募中
不适用
Prospective Study of the Efficacy, Safety and Identification of Predictors of Gefapixant for Refractory Chronic CoughRefractory Chronic CoughJPRN-UMIN000047917Japanese Red Cross Medical Center50
进行中（未招募）
1 期
Evaluation of the efficacy and safety of topical treatment on clinical signs and symptoms of dry eye disease associated with moderate meibomian gland dysfunction”EUCTR2021-003469-36-ESaboratorios Théa, S.A.54
已完成
不适用
Prospective evaluation of the efficacy and safety of a dermal filler familyL80-L99Other disorders of the skin and subcutaneous tissueDRKS00025937niCare GmbH137
招募中
不适用
Prospective evaluation of the safety and efficacy of MR-guided single-fraction stereotactic ablative radiotherapy for unresectable primary or secondary liver tumors - SINGLE SHOT LIVERC22C78.7Malignant neoplasm of liver and intrahepatic bile ductsSecondary malignant neoplasm of liver and intrahepatic bile ductDRKS00027117Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Klinikum Grosshadern der LMU München35